Approvals/TGA/VIMIZIM elosulfase alfa (rch) 1 mg/mL concentrated solution for injection vial

Approved

STANDARD

VIMIZIM elosulfase alfa (rch) 1 mg/mL concentrated solution for injection vial

Approval Id: 655a041172da75f9
Product Name: VIMIZIM elosulfase alfa (rch) 1 mg/mL concentrated solution for injection vial
Artg Id: 215523
Artg Name: VIMIZIM elosulfase alfa (rch) 1 mg/mL concentrated solution for injection vial
Sponsor: BioMarin Pharmaceutical Australia Pty Ltd
Company Detail Path: /organization/biomarin-pharmaceutical-australia-pty-ltd
Artg Date: 2014-12-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/4ca3fd488210856795e5470ba8bd6485.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/917e4762d8900f72e82bb675e03afe9a.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

655a041172da75f9

Type

Standard